The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world analyses of BRAF alterations in patients with non-colorectal gastrointestinal cancers.
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; QED Therapeutics; Taiho Oncology
Speakers' Bureau - AstraZeneca
Research Funding - Taiho Pharmaceutical
 
Emily Teslow
Employment - Tempus
Travel, Accommodations, Expenses - Tempus
 
Ellen B. Jaeger
Employment - Tempus; Tempus
Stock and Other Ownership Interests - Tempus
 
Melissa Conrad Stoppler
Employment - Gilead Sciences (I); Roche/Genentech (I); Roche/Genentech (I); Tempus
Stock and Other Ownership Interests - Exact Sciences; Gilead Sciences (I); Roche/Genentech (I); Tempus
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); QED Therapeutics (Inst)
 
AMR MOHAMED
Honoraria - Ipsen; Triple A
Consulting or Advisory Role - Triple A
Speakers' Bureau - Ipsen
Research Funding - Novatek Pharmaceuticals
 
Melissa Amy Lumish
No Relationships to Disclose
 
Madison Conces
No Relationships to Disclose
 
Sakti Chakrabarti
Honoraria - BioMedical Insights; Cancer Expert Now; HalioDx; Histosonics; Natera; omnihealth Media; QED Therapeutics
Speakers' Bureau - Bristol Myers Squibb; Merck; Natera; Seagen
(OPTIONAL) Uncompensated Relationships - Binacea